Tauroursodeoxycholic acid suppresses biliary epithelial cell apoptosis and endoplasmic reticulum stress by miR-107/NCK1 axis in a FXR-dependent manner
Authors:
- 8 January 2024
- journal article
- research article
- Published by Taylor & Francis in Drug and Chemical Toxicology
- Vol. 47 (6) , 839-847
Abstract
Tauroursodeoxycholic acid (TUDCA) can activate farnesoid X receptor (FXR) to involve in the formation of gallstones. Here, this study aimed to probe the potential mechanism of TUDCA-FXR network in the formation of bile duct stone. The levels of TUDCA, FXR and NCK1 were decreased, while the level of miR-107 was increased in the serum of bile duct stone patients. FXR expression was positively correlated with TUDCA or NCK1 expression in patients, moreover, TUDCA pretreatment in biliary epithelial cells increased the levels of FXR and NCK1, and rescued the decrease of NCK1 caused by FXR knockdown in cells. Then functional analysis showed FXR knockdown caused apoptosis and endoplasmic reticulum stress (ERS) as well as suppressed proliferation in biliary epithelial cells in vitro, which were attenuated by TUDCA pretreatment or NCK1 overexpression Mechanistically, NCK1 was a target of miR-107, which was up-regulated by FXR silencing, and FXR knockdown-induced decrease of NCK1 was rescued by miR-107 inhibition. Additionally, miR-107 expression was negatively correlated with TUDCA expression in bile duct stone patients, and TUDCA pretreatment in biliary epithelial cells decreased miR-107 expression by FXR. Functionally, the pretreatment of TUDCA or FXR agonist suppressed miR-107-evoked apoptosis and ERS in biliary epithelial cells. In conclusion, TUDCA up-regulates FXR expression to activate NCK1 through absorbing miR-107, thus suppressing the apoptosis and ERS in biliary epithelial cells, these results provided a theoretical basis for elucidating the mechanism of bile duct stone formation.Keywords
Funding Information
- Medical and Health Program of Zhejiang Province (No.2021KY1234)
This publication has 28 references indexed in Scilit:
- Endoplasmic Reticulum Stress Emerges as Novel Regulator for Bile Acid SynthesisCellular and Molecular Gastroenterology and Hepatology, 2017
- Novel FXR (farnesoid X receptor) modulators: Potential therapies for cholesterol gallstone diseaseBioorganic & Medicinal Chemistry, 2016
- Inhibition of mitochondrial β-oxidation by miR-107 promotes hepatic lipid accumulation and impairs glucose tolerance in vivoInternational Journal of Obesity, 2015
- Endoscopic ultrasound versus magnetic resonance cholangiopancreatography for common bile duct stonesCochrane Database of Systematic Reviews, 2015
- miR-107 orchestrates ER stress induction and lipid accumulation by post-transcriptional regulation of fatty acid synthase in hepatocytesBiochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms, 2014
- Protective effects of farnesoid X receptor (FXR) on hepatic lipid accumulation are mediated by hepatic FXR and independent of intestinal FGF15 signalLiver International, 2014
- Is the FXR the Fix for Cholesterol Gallstone Disease? *Hepatology, 2005
- Nck/Dock: an adapter between cell surface receptors and the actin cytoskeletonOncogene, 2001
- The Continuing Importance of Bile Acids in Liver and Intestinal DiseaseArchives of internal medicine (1960), 1999
- An analysis of data on human hepatic bile. Relationship between main bile components, serum cholesterol and serum triglyceridesScandinavian Journal of Clinical and Laboratory Investigation, 1977